KIT and bladder transitional cell carcinoma: Recognizing some morphological features and subtypes of urothelial carcinoma could be a useful prognostic factor in treatment planning; thus, schistosomal/urothelial bladder cancer should be considered a histological variant being positively correlated with T staging and CD117/KIT overexpression.